About

Sakura Bio is an innovative biotech company transforming cell therapy for cancer with effective, durable, and accessible T and NK cell treatments. Their core technology, T-Boost, enhances the potency, persistence, and resistance of reprogrammed T and NK cells against the tumor microenvironment. They aim to develop next-generation T/NK cell therapies with superior potency and durability to drive long-lasting clinical responses.

Key facts

At-a-glance profile data

Website: sakurabio.com
Headquarters: Cambridge, United States
Founded: 2017
Employees: 4
Total funding: -
Business model: B2B

Tech stack

Detected on sakurabio.com, last scanned 22 Aug 2026. Run your own scan

Observability: Sentry
CMS / Builders: Wix
CDN: Cloudflare
Email provider: Microsoft 365

Add first review

Frequently asked

How many employees does Sakura Bio have?

Sakura Bio has approximately 4 people on record.

What is Sakura Bio's current status?

Sakura Bio's current operating status is: Inactive.